Noticias de Eulerpool Innovent Biologics

Innovent Biologics Noticias de Acciones

Innovent Biologics es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de Innovent Biologics.

• 17 de junio ·

  Yahoo
  High Growth Tech Stocks in Asia Featuring 3 Promising Picks
• 16 de junio ·

  Yahoo
  Innovent Announces Completion of First Participant Dosed in the Seventh Phase 3 Clinical Trial (GLORY-OSA) of Mazdutide in China
• 13 de junio ·

  Yahoo
  Innovent to Present Multiple R&D Results of General Biomedicine Pipeline at the ADA's 85th Scientific Sessions
• 5 de junio ·

  Yahoo
  Innovent's IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) Receives Second NMPA Breakthrough Therapy Designation for Immuno-resistant Squamous Non-Small Cell Lung Cancer
• 3 de junio ·

  Yahoo
  Asian Market: Discovering 3 Stocks That May Be Trading Below Their Estimated Value
• 29 de mayo ·

  Yahoo
  Innovent Announces a Phase 3 Study of Picankibart (Anti-IL-23p19 Antibody) Completes First Participant Dosing, Exploring Biologics Switching Treatment for Psoriasis Patients with Prior Inadequate Response to Anti-IL-17 Antibodies
• 19 de mayo ·

  Yahoo
  Innovent Released 2024 ESG Report, Underscoring Commitment to Sustainable Development and Global Innovation
• 16 de mayo ·

  Yahoo
  Second Head-to-head Phase 3 Study of Mazdutide versus Semaglutide Completes First Participant Dosing in Adults in China with Overweight or Obesity Accompanied Fatty Liver Disease (GLORY-3)
• 9 de mayo ·

  SeekingAlpha
  Biotech Outperformance - Can't Take What's Already Earned
• 28 de abril ·

  Yahoo
  2025 AACR | Innovent Presents Preclinical Data of Multiple Novel Molecules including Bispecific and Tri-specific Antibodies and Bispecific ADCs